| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | -31415.32% | -3053.20% |
| EBITDA Margin | — | — | — | — | — | — | — | — | — | — | -30452.26% | -2924.08% |
| Net Margin | — | — | — | — | — | — | — | — | — | — | -31154.04% | -3234.05% |
| Current Ratio | 23.33 | 2.37 | 2.09 | 4.26 | 8.00 | 18.78 | 7.45 | 1.23 | 20.70 | 4.23 | 1.55 | 2.31 |
| Quick Ratio | 23.16 | 2.37 | 2.09 | 4.26 | 8.00 | 18.78 | 7.45 | 1.23 | 20.70 | 4.23 | 1.55 | 2.31 |
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE | -16.95% | -324.16% | -238.61% | -180.66% | -78.67% | -37.72% | -22.98% | -547.66% | -76.16% | -569.75% | 10895.85% | -557.70% |
| ROA | -16.12% | -189.74% | -128.98% | -138.07% | -67.47% | -34.89% | -19.52% | -118.88% | -68.87% | -286.91% | -171.61% | -100.97% |
| Asset Turnover | — | — | — | — | — | — | — | — | — | — | 0.01 | 0.03 |
| Book Value / Share | 1.69 | 0.23 | 0.44 | 1.00 | 2.02 | — | — | — | — | — | -0.00 | 0.10 |
Microbot Medical Inc. is a cutting-edge medical device company focused on enhancing healthcare through innovative technologies. The company's primary function is to develop micro-robotic medical solutions, with an emphasis on improving minimally invasive surgeries and medical procedures. This focus addresses the growing demand for precision, efficacy, and less invasive treatment options within the healthcare sector. Notably, Microbot Medical Inc. is pioneering advancements in the field of robotic technology to facilitate endoluminal procedures, which involve navigation through natural body lumens such as blood vessels or the gastrointestinal tract. With its headquarters in Massachusetts, USA, the company plays a significant role in the medical device market, contributing to the ongoing evolution of surgical practices and patient care. As healthcare providers increasingly prioritize technological advancements to reduce recovery times and enhance procedural accuracy, Microbot Medical Inc.'s innovations become crucial to achieving these goals. The company's commitment to micro-robotics positions it as a transformative entity within the healthcare technology landscape.